1. Home
  2. TALK vs FTRE Comparison

TALK vs FTRE Comparison

Compare TALK & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talkspace Inc.

TALK

Talkspace Inc.

HOLD

Current Price

$5.17

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.59

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALK
FTRE
Founded
2012
1996
Country
United States
United States
Employees
521
N/A
Industry
Medical/Nursing Services
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
788.5M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TALK
FTRE
Price
$5.17
$9.59
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$6.42
$14.17
AVG Volume (30 Days)
5.5M
978.7K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$26.02
N/A
Revenue Next Year
$21.24
$3.01
P/E Ratio
$155.55
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.22
$3.97
52 Week High
$5.20
$18.67

Technical Indicators

Market Signals
Indicator
TALK
FTRE
Relative Strength Index (RSI) 64.39 46.40
Support Level $4.59 $8.80
Resistance Level $5.19 $11.22
Average True Range (ATR) 0.02 0.66
MACD -0.03 0.13
Stochastic Oscillator 64.29 52.17

Price Performance

Historical Comparison
TALK
FTRE

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: